Reports Under the Securities Exchange Act of 1934. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell Registrable Securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to:
Appears in 4 contracts
Samples: Investors’ Rights Agreement (Marinus Pharmaceuticals Inc), Common Stock Purchase Agreement (Orexigen Therapeutics, Inc.), Investors’ Rights Agreement (Orexigen Therapeutics, Inc.)
Reports Under the Securities Exchange Act of 1934. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell Registrable Securities securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to:
Appears in 3 contracts
Samples: Registration Rights Agreement (Ep Medsystems Inc), Investors' Rights Agreement (Doubletwist Inc), Registration Rights Agreement (Ep Medsystems Inc)
Reports Under the Securities Exchange Act of 1934. With a view to toward making available to the Holders Investor the benefits of SEC Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder the Investor to sell its Registrable Securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to:
Appears in 1 contract
Samples: Rights Agreement (Mail Com Inc)
